Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2026-01-05 @ 6:23 PM
Study NCT ID:
NCT03063632
Status:
COMPLETED
Last Update Posted:
2023-10-25
First Post:
2017-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-22
First Submit QC Date:
None
Study First Post Date:
2017-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-06-10
Results First Submit QC Date:
None
Results First Post Date:
2022-08-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-03
Last Update Post Date:
2023-10-25
Last Update Post Date Type:
ACTUAL